Pediatric Main Page

March 2010

FULL-TEXT ARTICLE
Task Shifting Routine Inpatient Pediatric HIV Testing Improves Program Outcomes
in Urban Malawi: A Retrospective Observational Study.
McCollum ED, Preidis GA, Kabue MM, et al PLoS One. 2010 Mar 10;5(3):e9626.
The Effect of a Structured Exercise Program on Nutrition and Fitness Outcomes in Human
Immunodeficiency Virus-Infected Children.
Miller TL, Somarriba G, Kinnamon DD, et al AIDS Res Hum Retroviruses. 2010 Mar 10.
Predicting Virologic Failure Among HIV-1-Infected Children Receiving Antiretroviral
Therapy in Tanzania: a Cross-Sectional Study.
Emmett SD, Cunningham CK, Mmbaga BT, et al J Acquir Immune Defic Syndr. 2010 Mar 5.
Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among
children born to HIV-infected women in Tanzania.
Kawai K, Msamanga G, Manji K, et al Br J Nutr. 2010 Mar 9:1-8.
Early diagnosis of human immunodeficiency virus-1 infection in infants with the NucliSens EasyQ
assay on dried blood spots.
Lilian RR, Bhowan K, Sherman GG. J Clin Virol. 2010 Mar 6.
High sustained virologic response rates in children with chronic hepatitis C
receiving peginterferon alfa-2b plus ribavirin.
Wirth S, Ribes-Koninckx C, Calzado MA, et al J Hepatol. 2010 Feb 4.
Diagnosis of pulmonary tuberculosis in children: new advances.
Zar HJ, Connell TG, Nicol M., et alExpert Rev Anti Infect Ther. 2010 Mar;8(3):277-88.
Efficacy of the scoring system, recommended by the Brazilian National Ministry of Health,
for the diagnosis of pulmonary tuberculosis in children and adolescents, regardless of
their HIV status.]
Pedrozo C, Sant'anna CC, March Mde F, Lucena SC. et al J Bras Pneumol. 2010 Feb;36(1):92-8.
Challenges faced by health workers in providing counselling services to HIV-positive children
in Uganda: a descriptive study.
Rujumba J, Mbasaalaki-Mwaka CL, Ndeezi G. J Int AIDS Soc. 2010 Mar 7;13(1):9.
Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children
in India.
Banerjee T, Pensi T, Banerjee D, Grover G. Ann Trop Paediatr. 2010;30(1):27-37.
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children.
Gantt S, Kakuru A, Wald A, Pediatr Blood Cancer. 2010 Mar 4;54(5):670-674.
The orphaning experience: descriptions from Ugandan youth who have lost parents to HIV/AIDS.
Harms S, Jack S, Ssebunnya J, Kizza R. Child Adolesc Psychiatry Ment Health. 2010 Feb 7;4:6

February 2010

17th CROI Citations

POSTER
Prevalence of Darunavir-associated Mutations in PI-naive and PI-experienced HIV-1-infected
Children in the UK
K Boyd, S Walker, D Dunn, et al
PDF Poster Abstract
POSTER
2-Year Evolution of Triglycerides and Cholesterol in Thai HIV-1-infected Children Receiving
First-line NVP or Efavirenz EFV-based Regimen
S Kanjanavanit, R Hansudewechakul, S Kim^, et al
PDF Poster Abstract
POSTER
Pharmacokinetic (PK), Safety, and Efficacy Data on Cohort IIA; Youth Aged 6 to 11 Years
from IMPAACT P1066: A Phase I/II Study to Evaluate Raltegravir (RAL) in HIV-1 Infected Youth
S Nachman, P Samson, E Acosta, et al
PDF Poster Abstract
POSTER
Antiretroviral Drug Resistance Mutations in HIV-1-infected Ugandan Children
Perinatally Exposed to Single-dose Nevirapine following Virologic Failure to
an NNRTI-based Regimen
V Musiime, F Ssali, I Nankya, et al
PDF Poster Abstract
POSTER
Effect of Lopinavir/Ritonavir on Lipids in HIV-infected Children
N Rakhmanina, J van den Anker, M K Scott, et al
PDF Poster Abstract
POSTER
Pharmacokinetics of Lopinavir/Ritonavir Crushed vs Whole Tablets in Children
H Diep, B Best, E Capparelli. et al
PDF Poster Abstract

POSTER
Pharmacokinetics of Efavirenz Dosed According to the WHO Weight-bands in Children in Uganda
S Bakeera-Kitaka, E Natukunda, L Kendall, et al
PDF Poster Abstract

POSTER
Outpatient Nutritional Recovery in HIV-infected Children with Acute Malnutrition in the Era of HAART
M Kim, C Cox, A Dave, et al
PDF Poster Abstract

POSTER
Persistence of Stunting after HAART in HIV-infected Children in South India
PGDN Pandian, P Chandran
PDF Poster Abstract

POSTER
Increased Risk of Severe but Reversible Anemia following Perinatal Exposure to Maternal
HAART in Infants in Botswana
S Dryden-Peterson R Shapiro
PDF Poster Abstract

POSTER
Validation of Utility of the WHO Clinical Criteria for ‘Presumptive Diagnosis’ of Severe
HIV Disease in Infants and Children under 18 Months Requiring ART in Situations
Where Virologic Testing Is Not Available
N Tumwesigye, J Kiwanuka, J Mwanga
PDF Poster Abstract

POSTER
Survival of Children HIV-infected Perinatally or through Breastfeeding: A Pooled Analysis of
Individual Data from Sub-Saharan Africa
R Becquet and UNAIDS Child Survival Working Group
PDF Poster Abstract

POSTER
Incidence of Early Virological Failure and the Evolution of Antiretroviral Drug Resistance Mutations
in Ugandan Children
J Achan, T Ruel, P Li, et al
PDF Poster Abstract

POSTER
CD4 T Cell Depletion, and Not Age, May Be a Driver of Abnormal CD4 Cell Compartments in
HIV-infected Children Initiating ART in Uganda
V Musiime, A S Walker, P Musoke, et al
PDF Poster Abstract

POSTER
IRIS-related Mortality in HIV-infected Children Admitted after Initiating ART in Uganda
J Orikiiriza, S Bakeera-Kitaka, D Boulware, et al
PDF Poster Abstract

POSTER
HIV Subtype D Is Associated with Rapid CD4 Decline in ART-naive Ugandan Children
T Ruel L A Eller, H Cao, et al
PDF Poster Abstract

POSTER
Growth Response to ART in HIV-infected Children from Lilongwe, Malawi
R Weigel, O Keiser, J Gumulira, et al
PDF Poster Abstract

POSTER
Safety and Efficacy of NRTI-only Antiretroviral Regimens in HIV-infected Children
M Neely, R Rutstein, G del Bianco. et al
PDF Poster Abstract

POSTER
Trends in Incidence of AIDS-defining and Non-AIDS-defining Cancer among HIV-infected Children
in the US, 1984 to 2006
S Twichell, B Loechelt, S Rana. et al
PDF Poster Abstract

POSTER
Heightened Inflammation Is Linked to Carotid Intima-media Thickness and Endothelial
Activation in HIV-infected Children
A Ross, M A O’Riordan, N Storer, et al
PDF Poster Abstract

POSTER
Prenatal Exposure to Antiretrovirals among HIV-exposed but Uninfected Children: Surveillance
Monitoring for ART Toxicities Study
Rd Griner, P Williams, J Read
PDF Poster Abstract

POSTER
Association of Vascular Biomarkers with Neurodevelopmental Outcomes in Children with Perinatally
Acquired HIV Infection
S Kapetanovic, E Leister, S Nichols, et al
PDF Poster Abstract

POSTER
Insulin Resistance and Other Metabolic Abnormalities in a Cohort of HIV-1 Vertically Infected Latin
American Children: The NISDI PLACES Protocol
R Hazra, L Freimanis Hance, J Pontes Monteiro. et al
PDF Poster Abstract

POSTER
Associations of Pro-inflammatory Cytokine Levels with Lipid Profiles, Growth, and Body Composition
in HIV-infected Children Initiating or Changing ART
J Cervia, C Chantry, M Hughes, et al|
PDF Poster Abstract

POSTER
Persistence of Stunting after HAART in HIV-infected Children in South India
PGDN Pandian, P Chandran, C Kandasamy, et al
PDF Poster Abstract

POSTER
Differences in Body Fat Distribution in HIV-infected vs HIV-uninfected Children
D Jacobson, K Patel, R Van Dyke, et al
PDF Poster Abstract

POSTER
Causes of Hospitalization for HIV⁺ Children: Comparison of the Pre-PCP Prophylaxis,
Pre-ART, and ART Era
T Sudjaritruk, L Aurpibul, T Puthanakit, et al
PDF Poster Abstract

POSTER
Impact of TB Co-infection on Viral Suppression Rates in HIV-infected Children
B Zanoni, H Zanoni^, H France, et al
PDF Poster Abstract

POSTER
Prevalence of Hepatitis Co-infection among HIV-infected Nigerian Children in the
Harvard PEPFAR ART Program
H Rawizza, S Ochigbo, C Chang, et al
PDF Poster Abstract

POSTER
Persistence of Protective Antibody to Hepatitis B, Japanese Encephalitis, Measles, Mumps, and
Rubella up to 3 Years after Revaccination in HIV-infected Children with Immune Recovery a
L Aurpibul, T Sujaridruk, M Lao-araya, et al
PDF Poster Abstract

POSTER
Efficacy of Trimethoprim-sulfamethoxazole Prophylaxis against Malaria in HIV-exposed
Uninfected Children until 2 Years of Age: A Randomized Clinical Trial
J Homsy, T Sandison E Arinaitwe, et al
PDF Poster Abstract

Lipodystrophy among Children on HAART at the Pediatric Infectious Diseases Clinic,
Mulago Hospital
T Piloya, A Kekitiinwa, M Kamya, S Bakeera

A Pharmacokinetic Study of Ritonavir-boosted Saquinavir in HIV-infected Children
4 Months to <6 Years Old
J Haznedar, A Zhang, E Labriola-Tompkins

Interim Results from IMPAACT P1066: Raltegravir (RAL) Oral Chewable Tablet (OCT) Formulation
in Children 6 to 11 Years
S Nachman, E Acosta, P Samson, et al

Virological and Immunological Responses in Infants Receiving a Lopinavir/Ritonavir
(LPV/r)-based Regimen
A Violari, M Cotton, T Duong, et al

2009 H1N1 Immunization in HIV-1 Perinatally Infected Children and Youth
P Flynn, S Nachman, S Spector, et al

Immunologic and Viral Dynamics among HIV-infected Children after Planned Treatment
Interruption: A Substudy of the Pediatric European Network for Treatment of AIDS 11 Trial.
D Sefe, Nl Klein, I Mosconi, et al

Treatment Outcomes among HIV-infected Infants and Young Children following Modifications to
Protease Inhibitor-based Therapy Due to TB Treatment
M Moodley, C Reitz, Lee Fairlie, et al

Association between HIV Infection, ARV Use and Neurodevelopmental Outcomes among Children
Aged 0 to 14 Years in Rural Uganda
H Brahmbhatt, J Kagaayi, M Boivin, et al

HIV Subtype A Is Associated with Impaired Neuropsychological Performance Compared to
Subtype D in ART-naïve Ugandan Children
T Rue, M Boivin, P Bangirana, et al

Journal Citations

High sustained virologic response rates in children with chronic hepatitis C
receiving peginterferon alfa-2b plus ribavirin.
Wirth S, Ribes-Koninckx C, Calzado MA, et al J Hepatol. 2010 Feb 4.
Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected
and uninfected children and youth in PACTG 1045.
Jacobson DL, Lindsey JC, Gordon CM, et al AIDS. 2010 Feb 16.
HIV is associated with thrombophilia and high D-dimer in children and adolescents.
Pontrelli G, Martino AM, Tchidjou HK, et al AIDS. 2010 Feb 17
Long-Term Efficacy and Safety of Fosamprenavir in Human Immunodeficiency
Virus-Infected Pediatric Patients.
Palladino C, Briz V, Policarpo SN, et al Pediatr Infect Dis J. 2010 Feb 12
Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy.
Lass-Flörl C. Expert Rev Anti Infect Ther. 2010 Feb;8(2):127-35.
Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected
children on antiretroviral therapy: a nested case-control study.
Judd A, Boyd KL, Stöhr W, AIDS. 2010 Feb 4
In Untreated HIV-1-Infected Children, PBMC-Associated HIV DNA Levels and Cell-Free
HIV RNA Levels Are Correlated to Distinct T-lymphocyte Populations.
Scott-Algara D, Rouzioux C, Blanche S, J Acquir Immune Defic Syndr. 2010 Feb 5, et al
FULL-TEXT PDF ARTICLE
Racial/Ethnic Disparities Among Children with Diagnoses of Perinatal HIV Infection
--- 34 States, 2004--2007.
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2010 Feb 5;59(4):97-9
An updated follow-up of chronic hepatitis C after three decades of observation
in pediatric patients cured of malignancy.
Cesaro S, Bortolotti F, Petris MG, et al Pediatr Blood Cancer. 2010 Feb 1
Chronic hepatitis C virus infection in children.
Mohan N, González-Peralta RP, Fujisawa T, et al J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):123-31.
Clinical course of de novo hepatitis B infection after pediatric liver transplantation.
Su WJ, Ho MC, Ni YH, Wu JF, et al Liver Transpl. 2010 Feb;16(2):215-21.